Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Pazdur

Showing results (1-10 of 468) with videos related to

Pageof 47
Sort By:
Journal of the Advanced Practitioner in Oncology|June 4, 2021
FDA and Its Role in Drug DevelopmentRichard Pazdur
Clinical Advances in Hematology & Oncology : H&O|September 17, 2005
The FDA's new oncology officeRichard Pazdur
Clinical Advances in Hematology & Oncology : H&O|February 18, 2017
The seamless approach to drug development in oncologyRichard Pazdur
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|November 4, 2004
The Jim interviewRichard Pazdur
Oncology (Williston Park, N.Y.)|June 16, 2006
PROs: defining clinical benefit from the patient's perspective. Draft guidance provides direction in evaluating patient-reported outcomesRichard Pazdur
The Oncologist|June 17, 2008
Endpoints for assessing drug activity in clinical trialsRichard Pazdur
The Lancet. Oncology|February 8, 2022
Importing oncology trials from China: a bridge over troubled waters?Harpreet Singh, Richard Pazdur
JAMA|March 26, 2026
The Geography of Pharmaceutical Innovation: The US and China in a New World OrderRichard Pazdur, Steven Usdin
Nature Reviews. Clinical Oncology|February 9, 2022
Approvals in 2021: dangling Accelerated Approvals, drug dosing, new approvals and beyondSteven Lemery, Richard Pazdur
Critical Reviews in Oncology/Hematology|May 15, 2002
Oncology drug development: United States Food and Drug Administration perspectiveSteven Hirschfeld, Richard Pazdur
Pageof 47

Showing results (1-10 of 468) with videos related to

Sort By:
Pageof 47
Journal of the Advanced Practitioner in Oncology|June 4, 2021
FDA and Its Role in Drug DevelopmentRichard Pazdur
Clinical Advances in Hematology & Oncology : H&O|September 17, 2005
The FDA's new oncology officeRichard Pazdur
Clinical Advances in Hematology & Oncology : H&O|February 18, 2017
The seamless approach to drug development in oncologyRichard Pazdur
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|November 4, 2004
The Jim interviewRichard Pazdur
Oncology (Williston Park, N.Y.)|June 16, 2006
PROs: defining clinical benefit from the patient's perspective. Draft guidance provides direction in evaluating patient-reported outcomesRichard Pazdur
The Oncologist|June 17, 2008
Endpoints for assessing drug activity in clinical trialsRichard Pazdur
The Lancet. Oncology|February 8, 2022
Importing oncology trials from China: a bridge over troubled waters?Harpreet Singh, Richard Pazdur
JAMA|March 26, 2026
The Geography of Pharmaceutical Innovation: The US and China in a New World OrderRichard Pazdur, Steven Usdin
Nature Reviews. Clinical Oncology|February 9, 2022
Approvals in 2021: dangling Accelerated Approvals, drug dosing, new approvals and beyondSteven Lemery, Richard Pazdur
Critical Reviews in Oncology/Hematology|May 15, 2002
Oncology drug development: United States Food and Drug Administration perspectiveSteven Hirschfeld, Richard Pazdur
Pageof 47